HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Connie L Sivinski Selected Research

CD40 Ligand (CD40L)

8/2002Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Connie L Sivinski Research Topics

Disease

2Neoplasms (Cancer)
08/2002 - 08/2002
1Melanoma (Melanoma, Malignant)
08/2002
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2002
1Adenocarcinoma
08/2002

Drug/Important Bio-Agent (IBA)

2AntigensIBA
08/2002 - 08/2002
2CytokinesIBA
08/2002 - 08/2002
1Interferon-gamma (Interferon, gamma)IBA
08/2002
1Lymphotoxin-alpha (Lymphotoxin)IBA
08/2002
1VaccinesIBA
08/2002
1Interleukin-4 (Interleukin 4)IBA
08/2002
1gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA
08/2002
1alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA
08/2002
1Interleukin-10 (Interleukin 10)IBA
08/2002
1Interleukin-12 (IL 12)IBA
08/2002
1Cancer VaccinesIBA
08/2002
1CD40 Ligand (CD40L)IBA
08/2002
1PerforinIBA
08/2002
1AntibodiesIBA
08/2002
1Neoplasm Antigens (Tumor Antigens)IBA
08/2002